Testing of new disulfiram analogues and the structurally related
carbamo(dithioperoxo)thioates in human breast cancer cell lines
with differing levels of expression of BCA2, including the isogenic
cell lines MDA-MB-231 (BCAlow/) and MDA-MB-231/ER (BCA2+),
revealed interesting results.2 Of particular note were the carbamo(
dithioperoxo)thioates derived from reaction of disulfiram